This study represents one of the largest examinations to date of racial differences in key molecular genetic biomarkers of DLBCL, specifically focusing on rearrangements in MYC, BCL2, and BCL6 genes and on gene fusions involving IGH::MYC and IGH::BCL2 and their interactions. The gene discussed is BCL6; the disease is diffuse large B-cell lymphoma.